Summary
Metabolic dysfunction-associated Steatotic Liver Disease (MASLD) has emerged as a pressing global health challenge, affecting a nearly 30% of adults worldwide and with limited therapeutic options. Its progressive form, metabolic dysfunction-associated steatohepatitis (MASH)...